CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 2,708,341
- Share change
- -189,548
- Total reported value
- $5,621,000
- Price per share
- $2.08
- Number of holders
- 20
- Value change
- -$446,941
- Number of buys
- 8
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4.3%
|
644,763
|
$1,818,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
4.2%
|
633,904
|
$1,788,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
377,984
|
$1,066,000 | — | 31 Mar 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
286,655
|
$808,000 | — | 31 Mar 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
188,243
|
$529,000 | — | 31 Mar 2022 | |
| BERKSHIRE ASSET MANAGEMENT LLC/PA |
13F
|
Company |
1.2%
|
182,141
|
$514,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.92%
|
138,902
|
$392,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.69%
|
103,818
|
$293,000 | — | 31 Mar 2022 | |
| Martin E. Cearnal |
3/4/5
|
Sr VP/Chief Commercial Officer, Director |
—
class O/S missing
|
163,473
|
$277,904 | — | 17 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.59%
|
89,083
|
$251,000 | — | 31 Mar 2022 | |
| Leo Pavliv |
3/4/5
|
SVP and Chief Development Off. |
—
class O/S missing
|
129,618
|
$220,351 | — | 31 May 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.48%
|
72,236
|
$203,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.28%
|
42,045
|
$119,000 | — | 31 Mar 2022 | |
| Sterling Financial Planning, Inc. |
13F
|
Company |
0.15%
|
22,031
|
$62,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.14%
|
20,617
|
$58,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
19,843
|
$56,000 | — | 31 Mar 2022 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.12%
|
17,623
|
$50,000 | — | 31 Mar 2022 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.11%
|
16,246
|
$46,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.09%
|
14,207
|
$40,000 | — | 31 Mar 2022 | |
| M Holdings Securities, Inc. |
13F
|
Company |
0.07%
|
10,750
|
$30,000 | — | 31 Mar 2022 | |
| Jonathan Griggs |
3/4/5
|
Director |
—
class O/S missing
|
14,803
|
$25,165 | — | 17 Mar 2021 | |
| Michael Bonner |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
11,720
|
$19,924 | — | 17 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
3,453
|
$10,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
3,280
|
$9,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
3,136
|
$9,000 | — | 31 Mar 2022 | |
| Oakworth Capital, Inc. |
13F
|
Company |
0.02%
|
3,052
|
$9,000 | — | 31 Mar 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
2,885
|
$8,000 | — | 31 Mar 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
1,700
|
$5,000 | — | 31 Mar 2022 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q2 2022
As of 30 Jun 2022,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,708,341 shares.
The largest 10 holders included
DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, BERKSHIRE ASSET MANAGEMENT LLC/PA, ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, and STATE STREET CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
24
Q2 2022 holders
20
Holder diff
-4
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.